With a full year sales of $1.2 million - I'd be happy with...

First 357 Last

Share
Profile

Follow
Hawk70

1,793 Posts.

568

20/09/24

09:36

Post #: 75758165
Share

Originally posted by FindMyBroker: ↑

I can tell you the response to your first question will no doubt be: "Expanding the available sites from 18,000 labs to 270,000 gp offices will expand the addressable market and expand the reach of the product. As the product is designated to point of care, the gp office is our primary target for sale and likely see further uptake of the product".

But I agree, there is sole focus on Febridx more than anything, likely because the Viradx product whilst marketable, it saturated with other products as well. Febridx is a unique product in market.

Question is, what revenue this quarter from the product sales would make people happy? Surely it needs to be well over $1.2Million given the half year sales and previous quarters saw similar numbers.

FY23 had $300,000 USD in sales
FY24 had $1.2Million USD in sales
FY25: xxx

If the quarter shows above the $1.2Million mark, surely they is a drastic increase in product sales, the market shouldn't ignore? Given CLIA waiver not provided, if that kind of quarterly revenue is received, with CLIA waiver, the revenue could be expanded 15x. Even if the lowest sales year is multiplied by the addressable market with CLIA waiver, the annual revenue could be as little as $4.5Million.

Expand

With a full year sales of $1.2 million - I'd be happy with $600,000 in Q1

It isn't a full quarter I believe (selling) and not yet into Northern Flu season.

Q1: $600,000

Q2: $1,200,000+

Sets up the rest of the financial year very well - assuming we don't get merged.

LDX Price at posting: 3.3¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Almonty Industries – Now it is getting critical!

MEM

Many are concerned about global falling birthrates. This diverse stock has solutions

MTM

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

First 357 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 2.9¢		Change 0.002(7.41%)		Mkt cap ! $21.70M

Open	High	Low	Value	Volume
2.8¢	2.9¢	2.8¢	$44.36K	1.538M

Buyers (Bids)

No.	Vol.	Price($)
2	104764	2.9¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	324100	5

View Market Depth

No.	Vol.	Price($)
2	104764	0.029
5	468600	0.028
3	218288	0.027
3	581461	0.026
7	641153	0.025

Price($)	Vol.	No.
0.030	324100	5
0.031	252105	5
0.032	51725	1
0.035	88000	1
0.037	493186	2

Last trade - 14.13pm 18/06/2025 (20 minute delay)

LDX (ASX) Chart

With a full year sales of $1.2 million - I'd be happy with...

Almonty Industries – Now it is getting critical!

Many are concerned about global falling birthrates. This diverse stock has solutions

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

With a full year sales of $1.2 million - I'd be happy with...

Top Stories

Almonty Industries – Now it is getting critical!

Many are concerned about global falling birthrates. This diverse stock has solutions

MTM Crit Metals hits +1,870% returns YoY – but fundamental questions remain

ASX Market Close: IT surges as Miners dumped | June 18, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News